Recovering Damaged Cells for Sequelae Caused by COVID-19 SARS-CoV-2

  • STATUS
    Recruiting
  • End date
    Oct 1, 2022
  • participants needed
    2000
  • sponsor
    All Natural Medicine Clinic, LLC
Updated on 2 June 2021

Summary

Post-acute sequelae of SARS-CoV-2 infection can cause multiple system function disorders, and complicated symptoms last for an extended period. The virus can cause this continued infection, or the virus causes immune system function disorder and post-infectious autoimmune disease. The clinical symptoms can be smell loss, taste loss to liver function disorder, kidney function failure, different. No matter how complicated the systems showed in the clinic, all of the symptoms are due to the specific cells being damaged. Our clinical study is focused on recovering the damaged structure and function of the cells that could restore the organ function back to normal or close to normal

Description

SARS-CoV-2 caused sequela is a pathological condition, and specific cells are damaged from a prior disease, injury, or attack. Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) is caused by an infection of SARS-CoV-2 and COVID-19 virus. The virus or virus-triggered disorder immunity attacks target tissue(s) and organ(s). No matter name of the virus and the cells, tissue(s), or organ(s), they all belong to the category of antigen and cause an immune response; this can induce inflammation or not depending on the immune system tolerance . While older patients may have an increased risk of developing severe disease or sequelae, young survivors have also reported symptoms months after acute infection of SARS-CoV-2, reported by the British Lung Foundation. Some infected people, referred to as long-haulers, experience a long period of symptoms. Characterization of the etiology and pathophysiology of late sequelae is underway and may reflect organ damage from the acute infection phase; manifestations of a persistent hyperinflammatory state even perform as autoimmune diseases. Rheumatic disease can also occur during the infection of COVID. Ongoing viral activity indicates an inadequate antibody response. Factors in addition to acute illness that may further complicate the picture include physical deconditioning at baseline or after a long disease course, pre-COVID-19 comorbidities, and psychological sequelae following a long or difficult disease course relating to lifestyle changes due to the pandemic. Likely, the persistent sequelae of COVID-19 represent multiple syndromes resulting from distinct pathophysiological processes along the spectrum of disease. So far, no specific medicine has been identified for treating the COVID-19 virus and post-acute sequelae of SARS-CoV-2. Due to the difficulty treating either SARS-CoV-2 or its caused sequelae, there is a very pessimistic suggestion: People must live with COVID-19 forever. Most people who contract coronavirus disease 2019 (COVID-19) infection recover entirely within a few weeks. However, the long-haulers continue to experience symptoms after their initial recovery. This condition has been called post-COVID-19 syndrome or "long COVID-19." Older people and people with many severe medical conditions are the most likely to experience lingering COVID-19 symptoms, but even young, otherwise healthy people can feel unwell for weeks to months after infection. The most common signs and symptoms that linger over time include fatigue, shortness of breath, cough, joint pain, and chest pain. Other long-term signs and symptoms may include muscle pain or headache, fast or pounding heartbeat, loss of smell or taste, memory and concentration or sleep problems, and rash or hair loss, the Mayo Clinic reported.

Virus infections have been long associated with autoimmune diseases, whether multiple sclerosis, diabetes, or myocarditis. Three potential mechanisms for virus-induced autoimmune disease or virus-induced immunopathology are molecular mimicry, bystander activation, and persistent virus infection.

Those prolonged symptoms are consistent with the internal physical pathological process. That can be the virus infection continuing, or the infection triggered an immune reaction in one or more physical locations when a person became infected with the COVID-19 virus.

Here is the critical point: when the structure of cells is destroyed, the result is the affected cell's function will be lost. Does the etiology directly destroy the antigen, or the virus trigger the disorder immunity to destroy the antigen? The results are the same: the antigen is under inflammation. Returning the damaged cells (antigen) to normal or close to normal states is the key to saving lives.

This raises questions concerning how can we protect those cells from becoming damaged and how can we return injured cells to their normal function? Regardless of whether the cell has been damaged directly by the virus infection, or another reason like disordered immunity, my clinical research will show how to solve those medical problems.

Details
Condition Hepatitis A, Glomerulonephritis, Endogenous depression, Depression, Insomnia, Reiter's syndrome, LIVER DISEASE, Hepatitis, Bipolar Disorder, Gastroesophageal Reflux, ANXIETY NEUROSIS, Nephritis, Guillain-Barre Syndrome, Depression (Major/Severe), Anxiety Disorders (Pediatric), Depression (Adolescent), Depression (Pediatric), Depression (Adult and Geriatric), Gastroesophageal Reflux Disease (GERD), Depression (Treatment-Resistant), Generalized Anxiety Disorder (GAD), Depressed, Generalized Anxiety Disorder (GAD - Pediatric), Bipolar Disorders (Pediatric), Anxiety Disorders, Manic Disorders, Liver Disorders, depressive disorder, depression, bipolar, gastroesophageal reflux disease, esophageal reflux, gerd, gastric reflux, gastro-oesophageal reflux, reactive arthritis, anxiety/depression, anxiety disorder, depressed mood, miserable, depressive disorders, acute hepatitis a, a hepatitis, Sequelae of; Infection, Post Infection Glomerulonephritis, Post-Infectious Peripheral Neuralgia, Post-Infectious Disorder (Disorder), Post-Infectious Parkinsonism, Post-Infectious Hypothyroidism, Post Infectious Osteoarthritis, Sequelae of; Infection, Post-Infectious Peripheral Neuralgia, Post-Infectious Disorder (Disorder), Post-Infectious Parkinsonism, Post-Infectious Hypothyroidism, Sequelae of; Infection, Post-Infectious Peripheral Neuralgia, Post-Infectious Disorder (Disorder), Post-Infectious Parkinsonism, Post-Infectious Hypothyroidism, Sequelae of; Infection, Post-Infectious Peripheral Neuralgia, Post-Infectious Disorder (Disorder), Post-Infectious Parkinsonism, Post-Infectious Hypothyroidism
Treatment FurWat, FurFat, PurApo, PurPhl, PurClo, PurInf, Smoliv, PurWet
Clinical Study IdentifierNCT04846010
SponsorAll Natural Medicine Clinic, LLC
Last Modified on2 June 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

The participants must receive medical herbs as a treatment method
Participants are not limited by age, sex, race, or location
Participants are including infants
Participants are including pregnant woman
The participants had an infection history of SARS-CoV-2 in past one month
The participants provide SARS-CoV-s diagnoses (Molecular or Antigen). Test was positive, now hold negative reports
Participants hold reports of immune system medics, like immunoglobulin M (IgM), immunoglobulin G (IgG)
Reports that is evidence of specific organ damaged, including assay reports or image reports
Participants must agree to take medical herbs for at least 3 months as one course continually
Participants must agree to repeat the assay and image test to monitor the treatment results
Participants must report their Manifestations clearly to investigators
Participants must agree to continue the next course of the treatment after the evaluation if it is necessary
The treatment goal is to become symptom-free, and experiment assays went to normal

Exclusion Criteria

Participants don't want to take medical herbs
Participants have symptoms of sequelae but is not caused by SARS-CoV-2 (COVID-19)
Participants have not symptoms after COVID-19 infection, no assays abnormal either
Participants don't want to repeat the experiment assays
Participants are in E.R. or ICU during the application or enrollment
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note